Blood clots are 'very rare' side effect to AstraZeneca's Covid vaccine, European drug regulator says

To ensure delivery to your inbox add email@mail.nbcnews.com to your contacts | View in browser Add NBC News to your contacts Unsubscribe from this email

Apr 07, 2021 Blood clots are 'very rare' side effect to AstraZeneca's Covid vaccine, European drug regulator says Unusual blood clots should be listed as "very rare" side effects of the Oxford-AstraZeneca Covid-19 vaccine, Europe's main drug regulator said Wednesday. Separately, the U.K. recommended people under 30 be vaccinated with Pfizer or Moderna, instead of AstraZeneca, due to the small number of reported blood clots in younger people. The announcement comes less than a month after the agency said the Oxford-AstraZeneca vaccine was "safe and effective" and after a number of countries, including Germany, France and Italy, suspended the AstraZeneca vaccine over concerns about blood clots. Read More Get the NBC News Mobile App Follow NBC News Check out all of NBCNEWS Newsletters here. Update Preferences | Unsubscribe | Contact | Privacy Update Preferences Unsubscribe Contact Privacy